Here are five trends:
1. The market is expected to grow at a compound annual growth rate of 8.3 percent.
2. It is projected to reach a value of $87.2 million in 2022.
3. The demand for platelet rich plasma therapy is expected to increase due to awareness of the multiple advantages of PRP therapy. Another key growth factor is the growing geriatric population in need of surgeries and treatments.
4. In 2013, the orthopedic application segment held 38 percent of the market for PRP therapy in Europe.
5. In 2013, EmCyte, Arthrex and Biomet dominated the market.
More articles on devices:
17 new device launches & releases — October 26, 2015
25 spine devices receive FDA 510(k) clearances in September
Asia Pacific to see greatest growth in minimally invasive neurosurgery devices market: 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
